News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
859,274 Results
Type
Article (87326)
Company Profile (759)
Press Release (771163)
Multimedia
Podcasts (167)
Webinars (27)
Section
Business (233012)
Career Advice (4137)
Deals (39785)
Drug Delivery (133)
Drug Development (91228)
Employer Resources (202)
FDA (18264)
Job Trends (17392)
News (397287)
Policy (39913)
Tag
Academia (3003)
Academic (2)
Accelerated approval (17)
Adcomms (35)
Allergies (123)
Alliances (56979)
ALS (139)
Alzheimer's disease (1665)
Antibody-drug conjugate (ADC) (217)
Approvals (18270)
Artificial intelligence (469)
Autoimmune disease (57)
Automation (25)
Bankruptcy (406)
Best Places to Work (12633)
BIOSECURE Act (22)
Biosimilars (156)
Biotechnology (484)
Bladder cancer (121)
Brain cancer (48)
Breast cancer (459)
Cancer (3682)
Cardiovascular disease (324)
Career advice (3552)
Career pathing (36)
CAR-T (237)
CDC (52)
Cell therapy (648)
Cervical cancer (32)
Clinical research (75128)
Collaboration (1327)
Company closure (4)
Compensation (882)
Complete response letters (57)
COVID-19 (2946)
CRISPR (80)
C-suite (541)
Cystic fibrosis (131)
Data (4030)
Decentralized trials (2)
Denatured (59)
Depression (106)
Diabetes (439)
Diagnostics (7071)
Digital health (32)
Diversity (11)
Diversity, equity & inclusion (49)
Drug discovery (226)
Drug pricing (174)
Drug shortages (36)
Duchenne muscular dystrophy (191)
Earnings (98683)
Editorial (54)
Employer branding (25)
Employer resources (171)
Events (132586)
Executive appointments (968)
FDA (20598)
Fibrodysplasia Ossificans Progressiva (3)
Friedreich's ataxia (5)
Frontotemporal dementia (12)
Funding (1184)
Gene editing (167)
Generative AI (45)
Gene therapy (513)
GLP-1 (1007)
Government (5364)
Grass and pollen (7)
Guidances (335)
Healthcare (20937)
HIV (48)
Huntington's disease (36)
IgA nephropathy (55)
Immunology and inflammation (235)
Immuno-oncology (19)
Indications (51)
Infectious disease (3174)
Inflammatory bowel disease (180)
Inflation Reduction Act (14)
Influenza (90)
Intellectual property (177)
Interviews (815)
IPO (17923)
IRA (59)
Job creations (5196)
Job search strategy (2863)
Kidney cancer (15)
Labor market (73)
Layoffs (632)
Leadership (32)
Legal (10148)
Liver cancer (91)
Longevity (12)
Lung cancer (526)
Lymphoma (255)
Machine learning (26)
Management (66)
Manufacturing (604)
MASH (129)
Medical device (14849)
Medtech (14869)
Mergers & acquisitions (22704)
Metabolic disorders (1119)
Multiple sclerosis (132)
NASH (23)
Neurodegenerative disease (205)
Neuropsychiatric disorders (56)
Neuroscience (2631)
NextGen: Class of 2025 (7687)
Non-profit (5095)
Now hiring (55)
Obesity (551)
Opinion (307)
Ovarian cancer (122)
Pain (158)
Pancreatic cancer (162)
Parkinson's disease (225)
Partnered (28)
Patents (398)
Patient recruitment (289)
Peanut (57)
People (66144)
Pharmaceutical (144)
Pharmacy benefit managers (26)
Phase I (23158)
Phase II (32627)
Phase III (24549)
Pipeline (2575)
Policy (287)
Postmarket research (3554)
Preclinical (10453)
Press Release (72)
Prostate cancer (186)
Psychedelics (51)
Radiopharmaceuticals (281)
Rare diseases (632)
Real estate (7420)
Recruiting (78)
Regulatory (27845)
Reports (64)
Research institute (2682)
Resumes & cover letters (650)
Rett syndrome (12)
RNA editing (15)
RSV (69)
Schizophrenia (124)
Series A (197)
Series B (145)
Service/supplier (30)
Sickle cell disease (78)
Special edition (25)
Spinal muscular atrophy (170)
Sponsored (40)
Startups (4318)
State (2)
Stomach cancer (17)
Supply chain (97)
Tariffs (87)
The Weekly (106)
Vaccines (1024)
Venture capital (66)
Weight loss (385)
Women's health (57)
Worklife (21)
Date
Today (138)
Last 7 days (587)
Last 30 days (2528)
Last 365 days (33767)
2025 (24813)
2024 (38139)
2023 (42568)
2022 (53929)
2021 (58724)
2020 (57666)
2019 (51338)
2018 (39124)
2017 (37190)
2016 (38330)
2015 (44433)
2014 (39673)
2013 (36268)
2012 (38416)
2011 (38383)
2010 (39616)
Location
Africa (1278)
Alabama (79)
Alaska (7)
Arizona (299)
Arkansas (14)
Asia (50868)
Australia (8933)
California (9114)
Canada (2780)
China (861)
Colorado (388)
Connecticut (408)
Delaware (251)
Europe (116861)
Florida (1338)
Georgia (307)
Hawaii (3)
Idaho (67)
Illinois (799)
India (47)
Indiana (446)
Iowa (19)
Japan (295)
Kansas (123)
Kentucky (36)
Louisiana (20)
Maine (76)
Maryland (1236)
Massachusetts (6856)
Michigan (304)
Minnesota (550)
Mississippi (4)
Missouri (114)
Montana (33)
Nebraska (26)
Nevada (106)
New Hampshire (76)
New Jersey (2532)
New Mexico (32)
New York (2495)
North Carolina (1383)
North Dakota (10)
Northern California (4073)
Ohio (285)
Oklahoma (19)
Oregon (50)
Pennsylvania (1900)
Puerto Rico (19)
Rhode Island (46)
South America (1655)
South Carolina (46)
South Dakota (1)
Southern California (3479)
Tennessee (147)
Texas (1424)
United States (33805)
Utah (271)
Virginia (240)
Washington D.C. (82)
Washington State (786)
West Virginia (4)
Wisconsin (94)
Wyoming (1)
There are 859,274 results that match your search.
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
Kura Oncology and Kyowa Kirin Launch Clinical Trial Evaluating Dual Inhibition of NPM1 and FLT3 Mutations in Patients with Newly Diagnosed Acute Myeloid Leukemia (AML)
October 1, 2025
·
5 min read
Press Releases
Appili Therapeutics and its Partner Vitalex Biosciences Awarded Contract from NIAID Valued at up to US$40 Million to Develop Fungal Vaccine VXV-01
October 1, 2025
·
7 min read
Press Releases
Spur Therapeutics to Present New Clinical Data on Its Gene Therapy Candidate in Gaucher Disease at Upcoming ESGCT Annual Congress
October 1, 2025
·
1 min read
Press Releases
Comphya Announces First Patient Implanted with CaverSTIM in U.S. Pilot Study at Johns Hopkins University School of Medicine
October 1, 2025
·
4 min read
Press Releases
Arvinas to Present Clinical Data for ARV-102, a PROTAC LRRK2 Degrader, at the 2025 International Congress of Parkinson’s Disease and Movement Disorders®
October 1, 2025
·
4 min read
Press Releases
BioCryst Completes Sale of European ORLADEYO® (berotralstat) Business
October 1, 2025
·
7 min read
Press Releases
Immatics Appoints Venkat Ramanan as Chief Financial Officer
October 1, 2025
·
5 min read
Press Releases
Neumora Therapeutics to Host Virtual R&D Day on October 27
October 1, 2025
·
4 min read
Press Releases
Biomea Fusion, Inc. Reports Inducement Grant under Nasdaq Listing Rule 5635(c)(4) - October 1, 2025
October 1, 2025
·
1 min read
Press Releases
Sagimet Biosciences Announces Dosing of First Participants in Phase 1 PK Clinical Trial for Denifanstat and Resmetirom Combination
October 1, 2025
·
8 min read
1 of 85,928
Next
